Checking box will enable automatic data updates
Roche Holdings Ltd ADR(RHHBY)OTC US
Today's Change
Delayed Last Update
Pre Market Change
Pre Market Last Update Pre Market Price
Volume
Day Low41.2400
Day High41.7000
Open:41.5800
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Latest News
Landmark Alzheimer's Prevention Trial Unable to Show Significantly Slower Cognitive Decline in Inherited Form of Disease
PR Newswire - Thu Jun 16, 12:05AM CDT
PR Newswire
Thu Jun 16, 12:05AM CDT
/PRNewswire/ -- A precedent-setting prevention trial in Colombia has found that the investigational medicine crenezumab did not slow or prevent decline in...
Genentech Provides Update on Alzheimer’s Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimer’s Disease
Business Wire - Thu Jun 16, 12:00AM CDT
Business Wire
Thu Jun 16, 12:00AM CDT
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), together with Banner Alzheimer’s Institute, today announced results from the Alzheimer’s Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease (ADAD) Colombia Trial....
Genentech Announces Positive Data from Broad Blood Cancer Portfolio at European Hematology Association Annual Meeting
Business Wire - Fri Jun 10, 12:00AM CDT
Business Wire
Fri Jun 10, 12:00AM CDT
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it is presenting new long-term follow-up results and subanalyses from clinical trials of its approved therapies, as well as data on investigational medicines...